Inventor · disambiguated record
Joachim Mierau
Also filed as: MIERAU JOACHIM
15 granted patents·15 pending applications·629 citations·filing 1981–2010
94Inventor score
Files withBOEHRINGER INGELHEIM PHARMA13BOEHRINGER INGELHEIM KG6THOMAE GMBH DR K3BOEHRINGER INGELHEIM INT2BOEHRINGER SOHN INGELHEIM2
Top patents by PatentIndex Score
30 records- 0198US4886812ATetrahydro-benzthiazoles, the preparation thereof and their use as intermediate products or as pharmaceuticalsTHOMAE GMBH DR K·Filed 1988·Granted Dec 12, 1989·130 cites·10 claims
- 0298US4843086ATetrahydro-benzthiazoles, the preparation thereof and their use as intermediate products or as pharmaceuticalsBOEHRINGER INGELHEIM KG·Filed 1987·Granted Jun 27, 1989·107 cites·40 claims
- 0398US4731374ATetrahydro-benzthiazoles, the preparation thereof and their use as intermediate products or as pharmaceuticalsTHOMAE GMBH DR K·Filed 1985·Granted Mar 15, 1988·129 cites·9 claims
- 0492US5719279AAsymmetrically substituted xanthinesBOEHRINGER INGELHEIM KG·Filed 1996·Granted Feb 17, 1998·140 cites·9 claims
- 0586US4393069A8-Arylalkyl-3-phenyl-3-nortropanols and salts thereofBOEHRINGER SOHN INGELHEIM·Filed 1981·Granted Jul 12, 1983·28 cites·6 claims
- 0685US6492377B1Imidazotriazolopyrimidines with adenosine-antagonistic activityBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Dec 10, 2002·17 cites·11 claims
- 0781US6191153B1Use of 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a pharmaceutical composition having an antidepressant activityBOEHRINGER INGELHEIM KG·Filed 2000·Granted Feb 20, 2001·16 cites·2 claims
- 0871US6187780B1Assymetrically substituted xanthine derivatives having adenosine A1 antagonistic activityBOEHRINGER INGELHEIM PHARMA·Filed 1999·Granted Feb 13, 2001·32 cites·9 claims
- 0964US2008051443A1Compounds for the reduction of excessive food intakePIEPER MICHAEL P·Filed 2007·Application pending·0 cites
- 1064US2008051444A1Compounds for the reduction of excessive food intakePIEPER MICHAEL P·Filed 2007·Application pending·0 cites
- 1162US2006223869A1Compounds for the reduction of excessive food intakeBOEHRINGER INGELHEIM PHARMA·Filed 2006·Application pending·0 cites
- 1260US2006030607A1Compounds for the reduction of excessive food intakeBOEHRINGER INGELHEIM PHARMA·Filed 2005·Application pending·0 cites
- 1360US2005032812A1Compounds for the reduction of excessive food intakeBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 1460US2005032843A1Compounds for the reduction of excessive food intakeBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 1559US6355652B1Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Mar 12, 2002·1 cites·14 claims
- 1659US5196454AMethod of treating disorders of the dopaminergic systems using 2,5-diaminotetralinesBOEHRINGER INGELHEIM KG·Filed 1990·Granted Mar 23, 1993·14 cites·7 claims
- 1755US2003087941A1Compounds for the reduction of excessive food intakeBOEHRINGER INGELHEIM PHARMA·Filed 2002·Application pending·0 cites
- 1853US2005032806A1Method for treating anhedonia using dopamine agonistsBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 1951US5053430AUse of 2,7-diamino-1,2,3,4-tetrahydronaphthalenes as medicaments, new 2,7-diamino-1,2,3,4-tetrahydronaphthalenes and processes for their preparationBOEHRINGER INGELHEIM KG·Filed 1989·Granted Oct 1, 1991·5 cites·6 claims
- 2050US5068325A4,5,7,8-tetrahydro-6H-thiazolo[5,4-d]azepines, their preparation and their use as pharmaceutical compositionsTHOMAE GMBH DR K·Filed 1989·Granted Nov 26, 1991·5 cites·12 claims
- 2148US6387921B1Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted May 14, 2002·0 cites·12 claims
- 2248US2004266794A1Pramipexole for the reduction of excessive food intake for childrenBOEHRINGER INGELHEIM INT·Filed 2004·Application pending·0 cites
- 2348US2005154009A1Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitorNEUROSEARCH AS·Filed 2004·Application pending·0 cites
- 2448US2003036548A1Method for treating anhedonia using dopamine agonistsBOEHRINGER INGELHEIM PHARMA·Filed 2002·Application pending·0 cites
- 2545US4981862ATetrahydrobenzothiazoles, and the preparation and use thereofBOEHRINGER INGELHEIM KG·Filed 1988·Granted Jan 1, 1991·3 cites·6 claims
- 2642US5006533ACertain 3-bromo-2,6-dimethoxybenzamides and pharmaceutical use thereofBOEHRINGER SOHN INGELHEIM·Filed 1989·Granted Apr 9, 1991·2 cites·5 claims
- 2742US2005182090A1Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonistBOEHRINGER INGELHEIM PHARMA·Filed 2005·Application pending·0 cites
- 2838US2005277664A1Monoamine neurotransmitter re-uptake inhibitor for the inhibition of beta-amyloid generationBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 2936US2010210626A1Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitorFRIEDL THOMAS·Filed 2010·Application pending·0 cites
- 3035US2005182089A1Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonistBOEHRINGER INGELHEIM PHARMA·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →